Prognostic significance of circulating microparticles in IgA nephropathy

Niharika Bharti1, Mohit Kumar Rai2, Snigdha Singh1

  • 1Departments of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India.

Abstract

Insights

Circulating microparticles (MPs) and endothelial microparticles (EnMPs) are elevated in IgA nephropathy (IgAN) and correlate with disease activity. These markers may serve as non-invasive predictors of renal outcomes in IgAN patients.

Area of Science:

  • Nephrology
  • Immunology
  • Vascular Biology

Background:

  • Endothelial injury is implicated in renal fibrosis pathogenesis.
  • Microparticles (MPs) are vesicles shed from activated or damaged cell surfaces.
  • Endothelial microparticles (EnMPs) are a specific type of MP originating from endothelial cells.

Purpose of the Study:

  • To analyze the presence of circulating MPs and EnMPs in IgA nephropathy (IgAN).
  • To correlate MP and EnMP levels with markers of endothelial injury and disease activity in IgAN.
  • To evaluate the potential of MPs and EnMPs as non-invasive biomarkers for IgAN.

Main Methods:

  • Quantification of circulating MPs and EnMPs using flow cytometry in IgAN patients, healthy controls, and lupus nephritis controls.
  • Analysis of EnMPs using specific antibodies (anti-CD31-FITC and anti-CD146-PE).
  • Correlation of MP and EnMP levels with serum von Willebrand Factor (vWF), Oxford MEST-C score, and renal outcomes, including a prospective validation group.

Main Results:

  • IgAN patients exhibited significantly higher levels of MPs, EnMPs, and vWF compared to controls.
  • Plasma levels of total MPs, EnMPs, and serum vWF correlated with hypertension and E1 on histology.
  • Elevated MPs (>130 counts/µl) and E1 were associated with a shorter time to doubling of serum creatinine, with high diagnostic accuracy for E1 detection.

Conclusions:

  • Circulating MPs and EnMPs are elevated in IgAN.
  • These microparticles correlate with specific histological findings (E1) in IgAN.
  • MPs and EnMPs show potential as non-invasive biomarkers for predicting disease activity and renal outcomes in IgAN.

Related Concept Videos